Patents by Inventor Xiaoming Zhang

Xiaoming Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10223741
    Abstract: A system server includes a database of two-dimensional images and a processor coupled to a hardware memory with instructions that in response to execution by the processor direct performance of operations. The operations include generating a digital model from the images in the database and communicating a first portion of the digital model as an enhanced view to a user device. The first portion corresponds to a first line of sight orientation of the user device as measured by an orientation sensor. The operations include receiving a signal based on sensor data measured by the orientation sensor. The signal indicates movement of the user device from the first line of sight orientation to a second line of sight orientation. In response, the method includes communicating a second portion of the digital model to the user device that corresponds to the second line of sight orientation of the user device.
    Type: Grant
    Filed: March 30, 2017
    Date of Patent: March 5, 2019
    Assignee: EBAY INC.
    Inventors: Marcus Shelksohn, Fernando Villarreal, Khashayar Dehdashtinejad, Matthew Wolf, Jordan Springstroh, Jonathan Zhang, Yuquan Yang, Xiaoming Zhang, Zoran Dukic
  • Publication number: 20190034992
    Abstract: Methods and systems to automatically respond to a request for product information are described. In one embodiment, a data collection module may collect product data over a network, identify that the product data is related to a particular product, and store the product data and an association between the product data and the particular product in a database. An instant messaging engine may receive a request for the product data after the product data is stored in the database and an interpreter module may identify, in response to the request, the request to correspond to the particular product and retrieve the product data based on the association between the particular product and the product data. The instant messaging engine may also transmit, using an instant messaging protocol, a response to the request, the response including the product data.
    Type: Application
    Filed: October 3, 2018
    Publication date: January 31, 2019
    Inventor: Xiaoming Zhang
  • Publication number: 20190010112
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: July 19, 2018
    Publication date: January 10, 2019
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • Publication number: 20180325867
    Abstract: The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent.
    Type: Application
    Filed: April 18, 2018
    Publication date: November 15, 2018
    Inventors: Xiaoming ZHANG, Edward F. SCHNIPPER, Andrew J. PERLMAN, James W. LARRICK
  • Publication number: 20180325866
    Abstract: The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent.
    Type: Application
    Filed: April 10, 2018
    Publication date: November 15, 2018
    Inventors: Xiaoming ZHANG, Edward F. SCHNIPPER, Andrew J. PERLMAN, James W. LARRICK
  • Patent number: 10121175
    Abstract: In one example, a data collection module collects product data over a network, identifies that the product data is related to a particular product, and stores the product data and an association between the product data and the particular product in a database. An instant messaging engine receives a request for the product data after the product data is stored in the database and an interpreter module identifies, in response to the request, the request to correspond to the particular product and retrieve the product data based on the association between the particular product and the product data. The instant messaging engine transmits, using an instant messaging protocol, a response to the request, the response including the product data.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: November 6, 2018
    Assignee: eBay Inc.
    Inventor: Xiaoming Zhang
  • Publication number: 20180305293
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: March 21, 2018
    Publication date: October 25, 2018
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • Publication number: 20180258603
    Abstract: A post driver and puller combo includes a hollow main cylinder capable of accommodating a fence post, and a post-pulling mechanism provided at an upper portion of the main cylinder and disposed transversely therethrough. The post-pulling mechanism is freely detachable from the main cylinder. A user can insert a fence post into the hollow main cylinder and hit the top of the fence post to drive it into the ground. To extract the post, the user places the main cylinder at one side of the post and uses the post-pulling mechanism to engage with the post so that it can be pulled out of the ground. The device is a combination of a fence post erection machine and a fence post extraction machine. The device is simple in structure, easy to assemble, light in weight, and easy to transport.
    Type: Application
    Filed: April 19, 2017
    Publication date: September 13, 2018
    Inventor: Xiaoming Zhang
  • Publication number: 20180235931
    Abstract: The disclosure relates to the use of neurokinin-1 (NK-1) antagonists, such as serlopitant, MK-0303 or MK-8478, in alleviating or suppressing cough (including acute, subacute and chronic cough) and urge to cough. The cough can have an unknown cause (idiopathic cough) or can be associated with any type of medical condition, such as a respiratory disorder. The NK-1 antagonist can be delivered by oral inhalation for more rapid peripheral and central antitussive action. Another antitussive agent in addition to the NK-1 antagonist can optionally be administered for the treatment of the cough or urge to cough, or the cough-associated medical condition.
    Type: Application
    Filed: January 17, 2018
    Publication date: August 23, 2018
    Inventors: Steven BASTA, Paul KWON, Xiaoming ZHANG, Cyrus K. BECKER, Meenakshi S. VENKATRAMAN
  • Patent number: 10053414
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: August 21, 2018
    Assignee: CORSAIR PHARMA, INC.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • Publication number: 20180170855
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: June 14, 2016
    Publication date: June 21, 2018
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • Publication number: 20180162829
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Application
    Filed: November 13, 2017
    Publication date: June 14, 2018
    Inventors: Cyrus K. BECKER, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG
  • Patent number: 9974769
    Abstract: The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: May 22, 2018
    Assignee: MENLO THERAPEUTICS INC.
    Inventors: Xiaoming Zhang, Edward F. Schnipper, Andrew J. Perlman, James W. Larrick
  • Patent number: 9968588
    Abstract: The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: May 15, 2018
    Assignee: MENLO THERAPEUTICS INC.
    Inventors: Xiaoming Zhang, Edward F. Schnipper, Andrew J. Perlman, James W. Larrick
  • Patent number: 9957220
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: March 29, 2017
    Date of Patent: May 1, 2018
    Assignee: CORSAIR PHARMA, INC.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • Publication number: 20180086730
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Application
    Filed: August 25, 2017
    Publication date: March 29, 2018
    Inventors: Cyrus K. BECKER, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG, Jürg Pfister
  • Publication number: 20180045988
    Abstract: A lighting jig and lighting method are disclosed. The lighting jig includes: a signal generator; a data signal circuit board connected with the signal generator, the data signal circuit board being configured to split the data signal and the scanning signal; at least one data signal probe piece connected with the data signal circuit board; and at least one scanning signal circuit board connected with the data signal circuit board, the scanning signal circuit board being connected with a scanning signal probe piece. The lighting jig improves the stability of signal loadings.
    Type: Application
    Filed: October 21, 2016
    Publication date: February 15, 2018
    Inventors: Shijun LI, Song WU, Xiaoming ZHANG
  • Publication number: 20180016222
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: June 8, 2017
    Publication date: January 18, 2018
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • Publication number: 20170364979
    Abstract: Methods and systems to automatically respond to a request for product information are described. In one embodiment, a data collection module may collect product data over a network, identify that the product data is related to a particular product, and store the product data and an association between the product data and the particular product in a database. An instant messaging engine may receive a request for the product data after the product data is stored in the database and an interpreter module may identify, in response to the request, the request to correspond to the particular product and retrieve the product data based on the association between the particular product and the product data. The instant messaging engine may also transmit, using an instant messaging protocol, a response to the request, the response including the product data.
    Type: Application
    Filed: August 30, 2017
    Publication date: December 21, 2017
    Inventor: Xiaoming Zhang
  • Patent number: 9845305
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable dosage. Transdermal applications can be used.
    Type: Grant
    Filed: October 18, 2016
    Date of Patent: December 19, 2017
    Assignee: CORSAIR PHARMA, INC.
    Inventors: Cyrus K. Becker, Jürg R. Pfister, Gwenaella Rescourio, Meenakshi S. Venkatraman, Xiaoming Zhang